Tigecycline Market to Reflect Tremendous Growth Potential With A CAGR Of 8.7% BY 2031
The tigecycline market is expected to grow at a CAGR of 8.7% during the forecast period (2022-2031). The major factors driving the growth of the tigecycline market are the rising incidence of hospital-acquired infections and the growing prevalence of antibiotic resistance. Additionally, the increasing number of clinical trials for tigecycline is expected to boost market growth over the forecast period. However, the high cost of tigecycline and its side effects are expected to restrain the market growth somewhat. The global tigecycline market is segmented by dosage form, indication, end user, and geography. By dosage form, the market is divided into…
- Date: November 17, 2022
- Author: Quintero
- Category: PharmiWeb